Renee Carroll joined Acer in January 2020 as Vice President of Regulatory Affairs. She has worked in the pharmaceutical industry for over 25 years with increasing responsibilities in regulatory affairs in all phases of development and commercialization of drug, biologic, and combination products. Prior to joining Acer, Ms. Carroll held senior positions during her 15-year tenure at Sunovion Pharmaceuticals (formerly Sepracor) and was responsible for all aspects of regulatory activities for the Respiratory franchise, including US approvals of multiple commercial products. She also led a dedicated program to harmonize and increase efficiency for review of US Advertising and Promotion activities. Her expertise spans multiple therapeutic areas including pulmonary, CNS and oncology and experience in both brand and consulting companies, including ViaCell, Paraxel, OraVax, and Alkermes. Ms. Carroll received an M.S. degree in Chemistry from Worcester Polytechnic Institute and a B.S. degree in Chemistry from Merrimack College. In addition, Ms. Carroll is certified in Regulatory Affairs (RAC).
